Fingerprint
Dive into the research topics of 'PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically